Evidence map›Paper›PMID 41866612›Full record

ArticleScientific reports2026

A contrastive learning framework with adaptive feature fusion for brain tumor classification.

Yating Peng, Song He, Lingle Chang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yating PengMedical College, Guizhou University, Guiyang, 550025, Guizhou, China.
Song HeInformation Department, The People's Hospital of Guizhou Province, Guiyang, 550025, Guizhou, China.
Lingle ChangDepartment of Anesthesiology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, 545006, Guangxi, China. llchanggy@foxmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate classification of brain tumors from MRI scans is critical for diagnosis and treatment planning, yet remains challenging due to high intra-class heterogeneity and subtle inter-class differences. While deep learning has shown promise in automating this task, existing models often lack the discriminative power to reliably capture fine-grained pathological features. To address these limitations, we propose a novel contrastive learning framework with adaptive feature fusion (AFF-CL). Our method introduces a dynamic label queue that stores historical labels, enabling the construction of multiple positive pairs from different images of the same class. This design injects explicit supervision into contrastive learning, where the multiple positive pairs provide comprehensive intra-class variation coverage, directly facilitating feature representations that minimize intra-class distance while maximizing inter-class separation. Furthermore, to capture multi-scale contextual information, we augment the model with a local input stream and design an adaptive feature fusion (AFF) module to intelligently integrate localized features with global representations. Extensive experiments on the public figshare dataset demonstrate that our framework achieves state-of-the-art performance, significantly outperforming existing methods. The proposed approach shows strong potential for enhancing the precision of computer-aided diagnosis in clinical practice.

Indexed as

Brain NeoplasmsDeep LearningAlgorithmsClassification AlgorithmsHumansMagnetic Resonance ImagingAdaptive feature fusionBrain tumor classificationContrastive learningDeep learning

Identifiers

PMID41866612
PMCPMC13149659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.